
Blueprint Medicines signs deals for up to $1.25B in cash, earnouts
Blueprint Medicines Corp. has struck deals with Sixth Street and Royalty Pharma plc to bring in up to $1.25 billion. Click here to view original post… […]
Blueprint Medicines Corp. has struck deals with Sixth Street and Royalty Pharma plc to bring in up to $1.25 billion. Click here to view original post… […]
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia Akebia to assume responsibility for regulatory review processes previously led by Otsuka CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ — Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a… Click here to view original post… […]
Strong evidence links processed meats to poor health outcomes, including heart disease, type 2 diabetes, and some forms of cancer—but are all types of processed meat equally bad? Click here to view original post… […]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–ROME Therapeutics announced a publication in PNAS which describes the first X-ray crystallography structure of an endogenous reverse transcriptase. Click here to view original post… […]
CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ — VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology processing platforms, today announced that it has secured $4 million in seed funding led by Moxxie Ventures with participation from NextGen Venture… Click here to view original post… […]
Steward Morton Hospital voted to ratify a new three-year contract on Wednesday that includes significant wage hikes for its nearly 400 registered nurses and health care workers. Following months of contentious talks, the agreement came together after the nurses took an equally overwhelming vote to authorize a strike if necessary… Click here to view original post… […]
The signing of the agreement followed separate unanimous authorizations by the boards of each organization, and a letter of intent signed in March. Click here to view original post… […]
Encapsulated vitamin A product significantly outperforms commercial products CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ — Particles for Humanity has selected the final product and manufacturing process for its stable form of vitamin A, PFH-VAP, that will be used in commercial scaling…. Click here to view original post… […]
The presentation slides from the NCI SBIR Workshop on June 29, 2022.
The post NCI SBIR Workshop Presentation appeared first on MassBio. Click here to view original post… […]
A new article by a Baystate Medical Center doctor suggests that transgender and gender expansive clinicians experience deep discrimination in their hospital systems. One participant described the discrimination as “death by 1,000 cuts.” Click here to view original post… […]
Copyright © 2022 Biotech Networks, LLC